Top compounds associated with response to SPINK14


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0071 0.8
mRNA Imatinib CTRPv2 pan-cancer AAC -0.0076 0.8
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.0075 0.8
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.0072 0.8
mRNA SNX-2112 GDSC1000 pan-cancer AAC -0.0062 0.8
mRNA IPA-3 GDSC1000 pan-cancer AAC -0.0068 0.8
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.0066 0.8
mRNA CEP-701 GDSC1000 pan-cancer AAC -0.0067 0.8
mRNA KIN001-260 GDSC1000 pan-cancer AAC -0.0062 0.8
mRNA IC-87114 CTRPv2 pan-cancer AAC -0.0075 0.8
Download CSV